Telerehabilitation in People with Multiple Sclerosis: A Scoping Review
Abstract
Introduction: A new coronavirus, called COVID-19, was discovered in Hubei, China in December 2019. In just one year, COVID-19 has infected more than 81 million people (as of December 29, 2020) worldwide. People with multiple sclerosis (MS) are a particularly vulnerable group during the disease. In such a situation, telerehabilitation approaches provide the main solutions to improve the disorders caused by inactivity in people with MS. This study was conducted to review the studies performed in the field of telerehabilitation in people with MS and to evaluate the effectiveness and feasibility of using this method in the face of the prevalence of COVID-19 for people with MS.
Materials and Methods: Research studies were searched and reviewed in 4 databases, including PubMed, Science-direct, Scopus, and Web of Science in the period 1995-2020. The inclusion criteria included articles using telerehabilitation interventions in people with MS and telehealth interventions in people with MS published between 1995 and 2020. These articles have been published in peer-reviewed journals. Group or single-case intervention research has been used.
Results: A total of 261 articles were found in the initial search based on keywords. In these articles, descriptions of telerehabilitation and telehealth were presented. Initially, after reviewing the searched articles, 223 articles were removed from the study process due to a lack of inclusion criteria. After that, the full texts of the remaining 38 articles were selected, at the end, 16 articles had the inclusion criteria and were included in the study.
Conclusion: Based on our findings on the benefits of using telerehabilitation to improve the cognitive, physical, and quality of life of people with MS, as well as its cost-effectiveness, it is recommended that people with MS under the conditions of the COVID-19 pandemic stay in quarantine. It is a good way to rehabilitate these people to prevent the further progression of the disease and maintain their quality of life. Of course, this approach is growing and due to the low quality of current studies, more research is needed.
Cascella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R. Features, evaluation, and treatment of coronavirus (covid-19). Treasure Island: StatPearls; 2021. [PMID]
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of covid-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. 2020; 8(4):420-2. [DOI:10.1016/S2213-2600(20)30076-X]
Moore K, Jones L, Ripoll S, Jones T, Yonally-Phillips E. Key considerations: Dying, bereavement and mortuary and funerary practices in the context of covid-19 [Internet] 2020. [Updated 2022 November]. Available from: [Link]
World Health Organization (WHO). Considerations for quarantine of individuals in the context of containment for coronavirus disease (covid-19): Interim guidance, 19 March 2020. Geneva: World Health Organization; 2020. [Link]
Sajed AN, Amgain K. Corona virus disease (covid-19) outbreak and the strategy for prevention. Europasian Journal of Medical Sciences. 2020; 2(2):1-3. [DOI:10.46405/ejms.v2i1.38]
Olivera-La Rosa A, Chuquichambi EG, Ingram GPD. Keep your (social) distance: Pathogen concerns and social perception in the time of covid-19. Personality and Individual Differences. 2020; 166:110200. [DOI:10.1016/j.paid.2020.110200] [PMID] [PMCID]
Reipert B. Multiple sclerosis: A short review of the disease and its differences between men and women. The Journal of Men’s Health and Gender. 2004; 1(4):334-40. [DOI:10.1016/j.jmhg.2004.10.005]
Sormani MP. An Italian programme for covid-19 infection in multiple sclerosis. The Lancet Neurology. 2020; 19(6):481-2. [DOI:10.1016/S1474-4422(20)30147-2]
Synnott E. Bridging the gap in multiple sclerosis rehabilitation during covid-19. Journal of Multiple Sclerosis. 2020; 7(1):1. [Link]
Motl RW, McAuley E, Snook EM. Physical activity and multiple sclerosis: A meta-analysis. Multiple Sclerosis Journal. 2005; 11(4):459-63. [DOI:10.1191/1352458505ms1188oa] [PMID]
Ferrier S, Dunlop N, Blanchard C. The role of outcome expectations and self-efficacy in explaining physical activity behaviors of individuals with multiple sclerosis. Behavioral Medicine. 2010; 36(1):7-11. [DOI:10.1080/08964280903521354] [PMID]
Doerksen SE, Motl RW, McAuley E. Environmental correlates of physical activity in multiple sclerosis: A cross-sectional study. International Journal of Behavioral Nutrition and Physical Activity. 2007; 4:49. [DOI:10.1186/1479-5868-4-49] [PMID] [PMCID]
Mousai M, Hassani-Mehraban A, Akbarfahimi M, Nabavi SM. Relationship between disability severity and activity of daily living in people with multiple sclerosis. Journal of Modern Rehabilitation. 2016; 10(1):7-12. [Link]
Aliabadi S, Khanmohammadi R, Olyaei G, Ghotbi N, Talebian S, Moghadasi AN. Comparison of the position sense of the knee joint in patients with multiple sclerosis and healthy controls. Journal of Modern Rehabilitation. 2019; 13(1):59-64. [DOI:10.32598/JMR.13.1.59]
Halabchi F, Alizadeh Z, Sahraian MA, Abolhasani M. Exercise prescription for patients with multiple sclerosis; Potential benefits and practical recommendations. BMC Neurology. 2017; 17(1):185. [DOI:10.1186/s12883-017-0960-9] [PMID] [PMCID]
Sosnoff JJ, Socie MJ, Sandroff BM, Balantrapu S, Suh Y, Pula JH, et al. Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis. Disability and Rehabilitation. 2014; 36(3):205-9. [DOI:10.3109/09638288.2013.782361] [PMID]
Kim Y, Lai B, Mehta T, Thirumalai M, Padalabalanarayanan S, Rimmer JH, et al. Exercise training guidelines for multiple sclerosis, stroke, and parkinson’s disease: Rapid review and synthesis. American Journal of Physical Medicine & Rehabilitation. 2019; 98(7):613-21. [DOI:10.1097/PHM.0000000000001174] [PMID] [PMCID]
Amatya B, Galea MP, Kesselring J, Khan F. Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review. Multiple Sclerosis and Related Disorders. 2015; 4(4):358-69. [DOI:10.1016/j.msard.2015.06.011] [PMID]
Rintala A, Hakala S, Paltamaa J, Heinonen A, Karvanen J, Sjögren T. Effectiveness of technology-based distance physical rehabilitation interventions on physical activity and walking in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials. Disability and Rehabilitation. 2018; 40(4):373-87. [DOI:10.1080/09638288.2016.1260649] [PMID]
Robb JF, Hyland MH, Goodman AD. Comparison of telemedicine versus in-person visits for persons with multiple sclerosis: A randomized crossover study of feasibility, cost, and satisfaction. Multiple Sclerosis and Related Disorders. 2019; 36:101258. [DOI:10.1016/j.msard.2019.05.001] [PMID]
Munn Z, Peters MD, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Medical Research Methodology. 2018; 18(1):143. [DOI:10.1186/s12874-018-0611-x] [PMID] [PMCID]
Arksey H, O’Malley L. Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology. 2005; 8(1):19-32. [DOI:10.1080/1364557032000119616]
Thirumalai M, Rimmer JH, Johnson G, Wilroy J, Young H-J, Mehta T, et al. TEAMS (tele-exercise and multiple sclerosis), a tailored telerehabilitation mhealth app: Participant-centered development and usability study. JMIR Mhealth Uhealth. 2018; 6(5):e10181. [DOI:10.2196/10181] [PMID] [PMCID]
Mercier HW, Ni P, Houlihan BV, Jette AM. Differential impact and use of a telehealth intervention by persons with MS or SCI. American Journal of Physical Medicine & Rehabilitation. 2015; 94(11):987-99. [DOI:10.1097/PHM.0000000000000291] [PMID]
Turner AP, Wallin MT, Sloan A, Maloni H, Kane R, Martz L, et al. Clinical management of multiple sclerosis through home telehealth monitoring: Results of a pilot project. International Journal of MS Care. 2013; 15(1):8-14. [DOI:10.7224/1537-2073.2012-012] [PMID] [PMCID]
Wood J, Finkelstein J. Telerehabilitation system to support multipronged exercise in patients with multiple sclerosis. Paper presented at: 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). 13-16 November 2017; Kansas City, USA. [DOI:10.1109/BIBM.2017.8217772]
Khan F, Amatya B, Kesselring J, Galea M. Telerehabilitation for persons with multiple sclerosis. Cochrane Database of Systematic Reviews. 2015(4):CD010508. [DOI:10.1002/14651858.CD010508.pub2]
Malik M, Lustberg M, Kumar A, Krupp L, Sherman K, Kapila V, et al. Upper extremity telerehabilitation for progressive multiple sclerosis (1667). Neurology. 2020; 94 (15 Supplement). [Link]
Ortiz Gutierrez R, Galan del Rio F, Cano de la Cuerda R, Alguacil-Diego IM, Arroyo González R, Miangolarra Page JC. A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patients. NeuroRehabilitation. 2013; 33(4):545-54. [DOI:10.3233/NRE-130995] [PMID]
Best P, Frontario A, Shaw M, Charvet L. Telerehabilitation reduces travel cost and time: A survey of participants with multiple sclerosis in an urban treatment setting (P5.2-094). Neurology. 2019; 92(15 Supplement). [Link]
Burns RB, Crislip D, Daviou P, Temkin A, Vesmarovich S, Anshutz J, et al. Using telerehabilitation to support assistive technology. Assistive Technology. 1998; 10(2):126-33. [DOI:10.1080/10400435.1998.10131970] [PMID]
Burton RL, O’Connell ME. Telehealth rehabilitation for cognitive impairment: Randomized controlled feasibility trial. JMIR Research Protocols. 2018; 7(2):e9420. [DOI:10.2196/resprot.9420] [PMID] [PMCID]
Charvet LE, Yang J, Shaw MT, Sherman K, Haider L, Xu J, et al. Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial. Plos One. 2017; 12(5):e0177177. [DOI:10.1371/journal.pone.0177177] [PMID] [PMCID]
Egner A, Phillips V, Vora R, Wiggers E. Depression, fatigue, and health-related quality of life among people with advanced multiple sclerosis: Results from an exploratory telerehabilitation study. NeuroRehabilitation. 2003; 18(2):125-33. [DOI:10.3233/NRE-2003-18205] [PMID]
Fakolade A, Finlayson M, Plow M. Using telerehabilitation to support people with multiple sclerosis: A qualitative analysis of interactions, processes, and issues across three interventions. British Journal of Occupational Therapy. 2017; 80(4):259-68. [DOI:10.1177/0308022617690405]
Finkelstein J, Lapshin O, Castro H, Cha E, Provance PG. Home-based physical telerehabilitation in patients with multiple sclerosis: A pilot study. Journal of Rehabilitation Research & Development. 2008; 45(9):1361-73. [DOI:10.1682/JRRD.2008.01.0001] [PMID]
Finkelstein J, Liu J. Usability of telerehabilitation system supporting multipronged exercise in patients with multiple sclerosis. Studies in Health Technology and Informatics. 2018; 251:281-4. [PMID]
Fjeldstad-Pardo C, Thiessen A, Pardo G. Telerehabilitation in multiple sclerosis: results of a randomized feasibility and efficacy pilot study. International Journal of Telerehabilitation. 2018; 10(2):55-64. [DOI:10.5195/ijt.2018.6256] [PMCID] [PMID]
Nikoloski Z, Alqunaibet AM, Alfawaz RA, Almudarra SS, Herbst CH, El-Saharty S, et al. Covid-19 and non-communicable diseases: Evidence from a systematic literature review. BMC Public Health. 2021; 21(1):1068. [DOI:10.1186/s12889-021-11116-w] [PMID] [PMCID]
Moss BP, Mahajan KR, Bermel RA, Hellisz K, Hua LH, Hudec T, et al. Multiple sclerosis management during the covid-19 pandemic. Multiple Sclerosis Journal. 2020; 26(10):1163-71. [DOI:10.1177/1352458520948231] [PMID] [PMCID]
Peretti A, Amenta F, Tayebati SK, Nittari G, Mahdi SS. Telerehabilitation: Review of the state-of-the-art and areas of application. JMIR Rehabilitation and Assistive Technologies. 2017; 4(2):e7511. [DOI:10.2196/rehab.7511] [PMID] [PMCID]
Yeroushalmi S, Maloni H, Costello K, Wallin MT. Telemedicine and multiple sclerosis: A comprehensive literature review. Journal of Telemedicine and Telecare. 2020; 26(7-8):400-13. [DOI:10.1177/1357633X19840097] [PMID]
Sastre-Garriga J, Tintoré M, Montalban X. Keeping standards of multiple sclerosis care through the covid-19 pandemic. Multiple Sclerosis Journal. 2020; 26(10):1153-6. [DOI:10.1177/1352458520931785] [PMID]
Stern M, Sorkin L, Milton K, Sperber K. Aging with multiple sclerosis. Physical Medicine and Rehabilitation Clinics. 2010; 21(2):403-17. [DOI:10.1016/j.pmr.2009.12.008] [PMID]
Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA. Multiple sclerosis epidemiology in east Asia, south east Asia and south Asia: A systematic review. Neuroepidemiology. 2016; 46(3):209-21. [DOI:10.1159/000444019] [PMID]
Dalgas U, Stenager E. Exercise and disease progression in multiple sclerosis: Can exercise slow down the progression of multiple sclerosis? Therapeutic Advances in Neurological Disorders. 2012; 5(2):81-95. [DOI:10.1177/1756285611430719] [PMID] [PMCID]
Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Multiple Sclerosis Journal. 2002; 8(2):161-8. [DOI:10.1191/1352458502ms779oa] [PMID]
Massetti T, Trevizan IL, Arab C, Favero FM, Ribeiro-Papa DC, de Mello Monteiro CB. Virtual reality in multiple sclerosis-a systematic review. Multiple Sclerosis and Related Disorders. 2016; 8:107-12. [DOI:10.1016/j.msard.2016.05.014] [PMID]
Blikman LJ, Huisstede BM, Kooijmans H, Stam HJ, Bussmann JB, van Meeteren J. Effectiveness of energy conservation treatment in reducing fatigue in multiple sclerosis: A systematic review and meta-analysis. Archives of Physical Medicine and Rehabilitation. 2013; 94(7):1360-76. [DOI:10.1016/j.apmr.2013.01.025] [PMID]
Schwehr NA, Kuntz KM, Enns EA, Shippee ND, Kingwell E, Tremlett H, et al. Informing medication discontinuation decisions among older adults with relapsing-onset multiple sclerosis. Drugs & Aging. 2020; 37(3):225-35. [DOI:10.1007/s40266-019-00741-1] [PMID] [PMCID]
Christodoulou C, MacAllister WS, McLinskey NA, Krupp LB. Treatment of cognitive impairment in multiple sclerosis: Is the use of acetylcholinesterase inhibitors a viable option? CNS Drugs. 2008; 22(2):87-97. [DOI:10.2165/00023210-200822020-00001] [PMID]
| Files | ||
| Issue | Vol 17 No 1 (2023) | |
| Section | Review Article(s) | |
| DOI | https://doi.org/10.18502/jmr.v17i1.11289 | |
| Keywords | ||
| Multiple sclerosis Telerehabilitation COVID-19 Scoping review | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
